163 related articles for article (PubMed ID: 38667295)
1. Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling.
Aljagthmi WA; Alasmari MA; Daghestani MH; Al-Kharashi LA; Al-Mohanna FH; Aboussekhra A
Cells; 2024 Apr; 13(8):. PubMed ID: 38667295
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3/AUF1 pathway.
Al-Jomah N; Al-Mohanna FH; Aboussekhra A
Carcinogenesis; 2021 Dec; 42(12):1439-1448. PubMed ID: 34718441
[TBL] [Abstract][Full Text] [Related]
3. The cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.
Hendrayani SF; Al-Khalaf HH; Aboussekhra A
J Biol Chem; 2014 Nov; 289(45):30962-76. PubMed ID: 25231991
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin (OPG) Upregulation Activates Breast Stromal Fibroblasts and Enhances Their Pro-Carcinogenic Effects through the STAT3/IL-6 Signaling.
Al-Nasrallah HK; Al-Ansari MM; Aboussekhra A
Cells; 2022 Oct; 11(21):. PubMed ID: 36359766
[TBL] [Abstract][Full Text] [Related]
5. p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.
Al-Ansari MM; Hendrayani SF; Shehata AI; Aboussekhra A
Oncogene; 2013 May; 32(18):2356-64. PubMed ID: 22751126
[TBL] [Abstract][Full Text] [Related]
6. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.
Al-Rakan MA; Hendrayani SF; Aboussekhra A
BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185
[TBL] [Abstract][Full Text] [Related]
7. The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts.
Hendrayani SF; Al-Harbi B; Al-Ansari MM; Silva G; Aboussekhra A
Oncotarget; 2016 Jul; 7(27):41974-41985. PubMed ID: 27248826
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin I (JSI-124)-dependent inhibition of STAT3 permanently suppresses the pro-carcinogenic effects of active breast cancer-associated fibroblasts.
Al-Harbi B; Aboussekhra A
Mol Carcinog; 2021 Apr; 60(4):242-251. PubMed ID: 33621387
[TBL] [Abstract][Full Text] [Related]
9. High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients.
Al-Tweigeri T; AlRaouji NN; Tulbah A; Arafah M; Aboussekhra M; Al-Mohanna F; Gad AM; Eldali AM; Elhassan TA; Aboussekhra A
Breast Cancer Res; 2022 Jul; 24(1):46. PubMed ID: 35821051
[TBL] [Abstract][Full Text] [Related]
10. miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts.
Al-Ansari MM; Aboussekhra A
Oncotarget; 2015 Oct; 6(30):30006-16. PubMed ID: 26338965
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer.
Sun X; Qu Q; Lao Y; Zhang M; Yin X; Zhu H; Wang Y; Yang J; Yi J; Hao M
BMC Cancer; 2019 Dec; 19(1):1180. PubMed ID: 31795965
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
13. Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts.
Al-Khalaf HH; Ghebeh H; Inass R; Aboussekhra A
Mol Cell Biol; 2019 Jan; 39(2):. PubMed ID: 30397077
[TBL] [Abstract][Full Text] [Related]
14. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
15. Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic.
Al-Rakan MA; Colak D; Hendrayani SF; Al-Bakheet A; Al-Mohanna FH; Kaya N; Al-Malik O; Aboussekhra A
J Pathol; 2013 Dec; 231(4):457-65. PubMed ID: 24009142
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.
Al-Khalaf HH; Al-Harbi B; Al-Sayed A; Arafah M; Tulbah A; Jarman A; Al-Mohanna F; Aboussekhra A
Mol Cell Biol; 2019 Jan; 39(2):. PubMed ID: 30397072
[TBL] [Abstract][Full Text] [Related]
17. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
[TBL] [Abstract][Full Text] [Related]
18. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
19. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]